BioHarvest Sciences Inc. Announces Appointment of Gavriel Lambert to the Board of Advisors Company News
BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment Pharmaceutical Investing
The Gummy Project Announces Another Milestone with Entry into Canadian Retail Market Life Science Investing
Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation Life Science Investing
Ambrx Biopharma Inc. to Present at the H.C. Wainwright Preclinical Cancer Drug Discover Conference Life Science Investing
Health Canada Approves OPDIVO® as Monotherapy for the Adjuvant treatment of Adults with Urothelial Carcinoma at High Risk of Recurrence after Undergoing Radical Resection of UC Pharmaceutical Investing
Kite's CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma Pharmaceutical Investing
